Skip to main
PTI
PTI logo

Proteostasis Therapeutics (PTI)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy Proteostasis Therapeutics (PTI) Stock

About Proteostasis Therapeutics (PTI)

Kineta, Inc. is a clinical-stage biotechnology company, which engages in the development of immunotherapies for cancer patients. Its pipeline includes immuno-suppression: aVISTA mAb and exhausted T-cells: aCD27 agonist mAb. The company was founded by Shawn P. Iadonato and Charles L. Magness in 2008 and is headquartered in Mercer Island, WA.
Market cap$4.55M
Today's volume
Revenue (TTM)
Avg. daily volume15.62K
EBITDA (TTM)-$9.15M
Open
Price / earnings ratio-0.50x
Today's range
Debt / equity
52 week range$0.18 - $1.15
5 year debt / equity-0.85x
Beta (LTM)0.59x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio0.06x
Ex-dividend date
Next earningsNov 16, 2020
Dividend payable date

Frequently Asked Questions (FAQ)

As of Jul 08, 2025, the market cap for PTI stock is $4.56M

The current P/E ratio for PTI stock is -0.5

The 52-week high for PTI stock is $1.15. The current PTI stock price $undefined is 100.00% below its 52-week high

The 52-week low for PTI stock is $0.18. The current PTI stock price $undefined has increased 100.00% from its 52-week low

No, the PTI stock does not pay dividends to its shareholders

How to buy PTI stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in PTI stock

    Navigate to the Explore page. Then, type PTI into the search bar. When you see PTI stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased PTI stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Proteostasis Therapeutics Stock Earnings

The value each PTI share was expected to gain vs. the value that each PTI share actually gained.

Proteostasis Therapeutics (PTI) reported earnings per share (EPS) of $0, estimates of $0 by . In the same quarter last year, Proteostasis Therapeutics's earnings per share (EPS) was $0. Proteostasis Therapeutics is expected to release next earnings on 11/16/2020, with an earnings per share (EPS) estimate of $0.

Buy Proteostasis Therapeutics (PTI) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.